The Morphology of Paca (Cuniculus paca) Testis with High Dose of Letrozole an Aromatase Inhibitor

被引：0
|
作者：
Simoes, Luciana Senna [1 ]
de Castro Sasahara, Tais Harumi [1 ]
Favaron, Phelipe Oliveira [1 ]
Leal, Leonardo Martins [2 ]
de Oliveira, Fabricio Singaretti [3 ]
Fratini, Paula [1 ]
Berger, Trish [4 ]
Fernandes Machado, Marcia Rita [3 ]
Miglino, Maria Angelica [1 ]
机构：
[1] Univ Sao Paulo FMVZ USP, Sch Vet Med & Anim Sci, Dept Surg, Av Prof Dr Orlando Marques de Paiva 87, BR-05508270 Sao Paulo, SP, Brazil
[2] Uninga Dept Med Vet, Fac Ingn, Rod PR 317,6114 Parque Ind Duzentos, BR-87035510 Maringa, PR, Brazil
[3] Univ State Sao Paulo FCAV UNESP, Dept Anim Morphol & Physiol, Via Acesso Prof Paulo Donato Castellane S-N, BR-14884900 Jaboticabal, SP, Brazil
[4] Univ Calif Davis, Dept Anim Sci, 1 Shields Ave, Davis, CA 95616 USA
来源：
INTERNATIONAL JOURNAL OF MORPHOLOGY | 2020年 / 38卷 / 06期
关键词：
Gonadal; Toxic; Spermatogenesis;
D O I：
暂无
中图分类号：
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号：
100101 ;
摘要：
The study reported the influence of the high and acute dose of Letrozole on the testis morphology in paca (Cuniculus paca), an aromatase inhibitor that reduces the endogenous estrogen, the essential hormone for spennatogenesis. Morphological changes were observed in seminiferous epithelium with germ cells with apoptotic characteristics and presence of vacuoles and nuclei in pycnose.
引用
收藏
页码：1525 / 1527
页数：3
相关论文
共 36 条
  • [21] A randomized, controlled trial of high dose vs. standard dose vitamin D for aromatase inhibitor-induced arthralgia in breast cancer survivors
    Niravath, P.
    Wang, T.
    Hilsenbeck, S. G.
    Lipscomb, K.
    Pavlick, A.
    Jiralerspong, S.
    Nangia, J.
    Ellis, M.
    Ademuyiwa, F.
    Cherian, M.
    Frith, A.
    Ma, C.
    Park, H.
    Rigden, C.
    Suresh, R.
    Osborne, C. K.
    Rimawi, M. F.
    CANCER RESEARCH, 2019, 79 (04)
  • [22] Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia
    Niravath, Polly
    Hilsenbeck, Susan G.
    Wang, Tao
    Jiralerspong, Sao
    Nangia, Julie
    Pavlick, Anne
    Ademuyiwa, Foluso
    Frith, Ashley
    Ma, Cynthia
    Park, Haeseong
    Rigden, Caron
    Suresh, Rama
    Ellis, Matthew
    Osborne, C. Kent
    Rimawi, Mothaffar F.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 177 (02) : 427 - 435
  • [23] Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia
    Polly Niravath
    Susan G. Hilsenbeck
    Tao Wang
    Sao Jiralerspong
    Julie Nangia
    Anne Pavlick
    Foluso Ademuyiwa
    Ashley Frith
    Cynthia Ma
    Haeseong Park
    Caron Rigden
    Rama Suresh
    Matthew Ellis
    C. Kent Osborne
    Mothaffar F. Rimawi
    Breast Cancer Research and Treatment, 2019, 177 : 427 - 435
  • [24] ACHIEVEMENT OF FERTILITY IN AN INFERTILE MAN WITH RESISTANT MACROPROLACTINOMA USING HIGH-DOSE BROMOCRIPTINE AND A COMBINATION OF HUMAN CHORIONIC GONADOTROPIN AND AN AROMATASE INHIBITOR
    Heidari, Zahra
    Hosseinpanah, Farhad
    Shirazian, Nahid
    ENDOCRINE PRACTICE, 2010, 16 (04) : 669 - 672
  • [25] High-dose toremifene as first-line treatment of metastatic breast cancer resistant to adjuvant aromatase inhibitor: A multicenter phase II study
    Sawaki, Masataka
    Wada, Masaki
    Sato, Yasuyuki
    Mizuno, Yutaka
    Kobayashi, Hironobu
    Yokoi, Kazuki
    Yoshihara, Motoi
    Kamei, Keitaro
    Ohno, Mototsugu
    Imai, Tsuneo
    ONCOLOGY LETTERS, 2012, 3 (01) : 61 - 65
  • [26] Phase II study of high-dose toremifene as first line treatment of metastatic breast cancer in patients with adjuvant aromatase inhibitor-resistance
    Sawaki, M.
    Wada, M.
    Sato, Y.
    Mizuno, Y.
    Kobayashi, H.
    Yokoi, K.
    Yoshihara, M.
    Kamei, K.
    Ohno, M.
    Imai, T.
    BREAST, 2011, 20 : S77 - S78
  • [27] AROMATASE INHIBITOR CO-TREATMENT WITH GONADOTROPIN REDUCES THE DOSE OF GONADOTROPN AND PEAK ESTRADIOL LEVEL WITHOUT COMPROMISING IVF OUTCOMES IN HIGH RESPONDER PATIENTS
    Lee, H. S.
    Jeong, H. J.
    Kim, M. H.
    Kim, J. W.
    Lee, J. H.
    Chung, M. K.
    FERTILITY AND STERILITY, 2013, 100 (03) : S109 - S109
  • [28] Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor-Positive, Aromatase Inhibitor-Resistant Advanced Breast Cancer A Phase 2 Randomized Study
    Ellis, Matthew J.
    Gao, Feng
    Dehdashti, Farrokh
    Jeffe, Donna B.
    Marcom, P. Kelly
    Carey, Lisa A.
    Dickler, Maura N.
    Silverman, Paula
    Fleming, Gini F.
    Kommareddy, Aruna
    Jamalabadi-Majidi, S.
    Crowder, Robert
    Siegel, Barry A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (07): : 774 - 780
  • [29] A randomized phase 2 trial of low dose (6 mg daily) versus high dose (30 mg daily) estradiol for patients with estrogen receptor positive aromatase inhibitor resistant advanced breast cancer
    Ellis, M. J.
    Dehdahti, F.
    Kommareddy, A.
    Jamalabadi-Majidi, S.
    Crowder, R.
    Jeffe, D. B.
    Gao, F.
    Fleming, G.
    Silverman, P.
    Dickler, M.
    Carey, L.
    Marcom, P. K.
    CANCER RESEARCH, 2009, 69 (02) : 67S - 68S
  • [30] Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months
    Frank, Denise H.
    Kimler, Bruce F.
    Fabian, Carol J.
    Ranger-Moore, James
    Yozwiak, Michael
    Bartels, Hubert G.
    Alberts, David S.
    Bartels, Peter H.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (03) : 661 - 668
1234